The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
N | Nervous system | |
2
|
N07 | Other nervous system drugs | |
3
|
N07X | Other nervous system drugs | |
4
|
N07XX | Other nervous system drugs | |
5
|
N07XX18 |
| Active Ingredient |
|---|
|
Vutrisiran is a chemically stabilized double-stranded small interfering ribonucleic acid (siRNA) that specifically targets variant and/or wild-type transthyretin (TTR) messenger RNA (mRNA). Vutrisiran causes the catalytic degradation of TTR mRNA in the liver, resulting in the reduction of serum levels of variant and wild-type amyloidogenic TTR protein thus reducing the deposition of TTR amyloid in tissues. |
| Document | Type | Information Source | |
|---|---|---|---|
| AMVUTTRA Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.